Nabil joins Rheos with over 15 years of experience across strategic and operational functions, including program & alliance management, portfolio planning, corporate strategy and business development. Most recently, he served as Vice President, Corporate Development at Concert Pharmaceuticals where he was responsible for corporate strategy, business development, program management and commercial planning. Nabil joined Concert to provide strategic and operational leadership for a program in cystic fibrosis that was ultimately acquired by Vertex Pharmaceuticals.
Prior to Concert, Nabil worked at Seaside Therapeutics, a company focused on neurodevelopmental disorders such as Fragile X Syndrome and autism spectrum disorders. Earlier in his career he served as a consultant providing strategic planning and program management services.
Nabil earned a B.Sc. in Biology from McMaster University, a Pharm.D. from the Massachusetts College of Pharmacy and completed a Post-Doctoral Fellowship at the University of North Carolina at Chapel Hill.